Form N-CEN/A JOHN HANCOCK TAX-ADVANTA For: Oct 31
Tweet
Share
E-mailX0303 N-CEN/A 0001145549-21-000387 LIVE 0001260041 XXXXXXXX true false false N-2 John Hancock Tax-Advantaged Dividend Income Fund 811-21416 0001260041 5493001RMBJ8FL02CN30 200 Berkeley Street Boston 02116 US-MA US 6176634497 State Street Bank and Trust Company One Lincoln Street Boston 02111 6177863000 SSB maintains the accounting records and the custody of the assets. John Hancock Tax-Advantaged Dividend Income Fund 200 Berkeley Street Boston 02116 6176634497 Records related to its functions as Registrant John Hancock Investment Management LLC 200 Berkeley Street Boston 02116 6176632430 Records related to its functions as advisor Manulife Investment Management (US) LLC 197 Clarendon Street Boston 02216 6173751876 Records related to its functions as sub-advisor Wells Capital Management Incorporated 525 Market Street San Francisco 94105 4153968000 Records related to its functions as sub-advisor N N N-2 Y Hassell H. McClellan N/A N James R. Boyle N/A N Peter S. Burgess N/A N William H. Cunningham N/A N Grace K. Fey N/A N Marianne Harrison N/A Y Deborah C. Jackson N/A N James M. Oates N/A N Gregory A. Russo N/A N Steven R. Pruchansky N/A N Andrew G. Arnott N/A Y Charles L. Bardelis N/A N Frances G. Rathke N/A N Trevor Swanberg 004213623 200 Berkeley Street Boston 02116 XXXXXX Y N N N N John Hancock Investment Management Distributors LLC 8-43582 000028262 N/A Y N PricewaterhouseCoopers LLP 00238 5493002GVO7EO8RNNS37 N N N N N N Tax-Advantaged Dividend Income Fund 5493001RMBJ8FL02CN30 N N/A N N Y N N/A N/A N/A Rule 23c-1 (17 CFR 270.23c-1) Rule 32a-4 (17 CFR 270.32a-4) Y Y N N John Hancock Investment Management LLC 801-8124 000105790 AOWFNEEIG2OJ03AZXK87 N Manulife Investment Management (US) LLC 801-42023 000106435 549300ZKXV1OCZQWDK34 Y N Wells Capital Management Incorporated 801-21122 000104973 549300B3H2IOO2L85I90 N N Computershare Inc 084-05925 254900Y7PP3ZED9AUY94 N N N Refinitiv 549300561UZND4C7B569 CA N ICE Data Services 5493000NQ9LYLDBCTL34 N Pricing Direct 549300WIC0TOJ7N7GD54 N IHS Markit N/A GB N Bloomberg LP N/A N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Computershare Shareowner Services, LLC 254900Y7PP3ZED9AUY94 N N N John Hancock Investment Management LLC AOWFNEEIG2OJ03AZXK87 Y N N William Blair 8-2698 000001252 549300J0P7XYE8BMZ775 33693.750000000000 BNY Mellon Capital Markets, LLC 8-35255 000017454 VJW2DOOHGDT6PR0ZRO63 22103.190000000000 National Financial Services LLC 8-26740 000013041 549300JRHF1MHHWUAW04 17535.300000000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 14907.120000000000 Credit Suisse AG N/A N/A ANGGYXNX0JLX3X63JN86 CH 13794.080000000000 Merrill Lynch, Pierce, Fenner & Smith Incorporated 8-7221 000007691 8NAV47T0Y26Q87Y0QP81 12194.250000000000 Virtu Americas LLC 8-68193 000149823 549300RA02N3BNSWBV74 7350.000000000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 6800.430000000000 Raymond James & Associates, Inc. 8-10999 000000705 U4ONQX15J3RO8XCKE979 4800.000000000000 Wells Fargo Securities, LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 4500.000000000000 154978.490000000000 State Street Global Markets, LLC 8-69862 000285852 549300FDEDF5ORXCMQ56 2094549902.000000000000 BNY Mellon Capital Markets, LLC 8-35255 000017454 VJW2DOOHGDT6PR0ZRO63 304167700.470000000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 289264864.390000000000 Barclays Bank PLC N/A N/A G5GSEF7VJP5I7OUK5573 GB 136455273.740000000000 UBS AG N/A N/A BFM8T61CT2L1QCEMIK50 CH 126699068.030000000000 Merrill Lynch, Pierce, Fenner & Smith Incorporated 8-7221 000007691 8NAV47T0Y26Q87Y0QP81 39784800.020000000000 Wells Fargo Securities, LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 28807893.450000000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 24373150.170000000000 Royal Bank of Canada N/A N/A ES7IP3U3RHIGC71XBU11 CA 15212886.640000000000 Mitsubishi UFJ Financial Group, Inc. N/A N/A 353800V2V8PUY9TK3E06 JP 14155898.480000000000 3133442843.380000000000 Y 813465960.980000000000 N Common stock Common shares N N N N N N 1.210000000000 1.960000000000 18.99 21.650000000000 true
Report of Independent Registered Public Accounting Firm
To the Board of Trustees and Shareholders of John Hancock Tax-Advantaged Dividend Income Fund
In planning and performing our audit of the financial statements of John Hancock Tax-Advantaged Dividend Income Fund (the “Fund”) as of and for the year ended October 31, 2020, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund’s internal control over financial reporting.
The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.
Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be material weaknesses as defined above as of October 31, 2020.
PricewaterhouseCoopers LLP, 101 Seaport Boulevard, Suite 500, Boston, MA 02210
T: (617) 530 5000, F: (617) 530 5001, www.pwc.com/us
This report is intended solely for the information and use of the Board of Trustees of John Hancock Tax-Advantaged Dividend Income Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
December 10, 2020
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Entergy Texas’ First Solar Resource Helps Customers Meet Sustainability Goals
- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting
- Melco reaffirms commitment to sustainability in 2023 RISE to go Above & Beyond report
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
